This inventor holds 1 USPTO granted patent. Top assignee: Onyx Pharmaceuticals, Inc.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Lelia Wu: Innovator in Biopharmaceuticals
Introduction
Lelia Wu is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of biopharmaceuticals, particularly through her innovative work on polypeptides and polynucleotides.
Latest Patents
Lelia Wu holds a patent for "P53-binding polypeptides and polynucleotides encoding same." This invention provides mammalian polypeptides that bind to both wild-type and mutant mammalian p53 proteins. The patent also includes polynucleotides encoding these polypeptides, as well as screening assays for drug development that utilize these polypeptides and polynucleotides. Additionally, it encompasses immunological and other reagents for diagnostic, therapeutic, and research applications.
Career Highlights
Lelia Wu is currently employed at Onyx Pharmaceuticals, Inc., where she continues to advance her research and development efforts in the biopharmaceutical sector. Her work has been instrumental in the exploration of new therapeutic avenues.
Collaborations
Lelia collaborates with various professionals in her field, including her coworker James R. Bischoff, to enhance the impact of her research and innovations.
Conclusion
Lelia Wu's contributions to the field of biopharmaceuticals through her patent and work at Onyx Pharmaceuticals, Inc. highlight her role as a key innovator in the industry. Her research continues to pave the way for advancements in drug development and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile